The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
Clifford R. Jack, Matt A. Bernstein, Nick C. Fox, Paul M. Thompson, Gene E. Alexander, Danielle Jenine Harvey, Bret Borowski, Paula J. Britson, Jennifer Louise Whitwell, Chadwick P. Ward, Anders Martin Dale, Joel P. Felmlee, Jeffrey L. Gunter, David Hill, Ronald Killiany, Norbert W. Schuff, Sabrina Fox‐Bosetti, Chen Lin, Colin Studholme, Charles S DeCarli, Gunnar Krüger, Heidi A. Ward, Gregory J. Metzger, Katherine T. Scott, Richard P. Mallozzi, Daniel J. Blezek, Joshua R. Levy, Josef P. Debbins, Adam Fleisher, Marilyn Albert, Robert C. Green, George Bartzokis, Gary H. Glover, John P. Mugler, Michael Walter Weiner
Journal of Magnetic Resonance Imaging · 2008 · 4,519 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P. M., Alexander, G. E., Harvey, D. J., Borowski, B., Britson, P. J., Whitwell, J. L., Ward, C. P., Dale, A. M., Felmlee, J. P., Gunter, J. L., Hill, D., Killiany, R., Schuff, N. W., Fox‐Bosetti, S., Lin, C., Studholme, C., … Weiner, M. W. (2008). The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods. Journal of Magnetic Resonance Imaging, 27(4), 685–691. https://doi.org/10.1002/jmri.21049
In text: (Jack et al., 2008)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a longitudinal multisite observational study of healthy elders, mild cognitive impairment (MCI), and Alzheimer's disease. Magnetic resonance imaging (MRI), (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), urine serum, and cerebrospinal fluid (CSF) biomarkers, as well as clinical/psychometric assessments are acquired at multiple time points. All data will be cross-linked and made available to the general scientific community. The purpose of this report is to describe the MRI methods employed in ADNI. The ADNI MRI core established specifications that guided protocol development. A major effort was devoted to evaluating 3D T(1)-weighted sequences for morphometric analyses. Several options for this sequence were optimized for the relevant manufacturer platforms and then compared in a reduced-scale clinical trial. The protocol selected for the ADNI study includes: back-to-back 3D magnetization prepared rapid gradient echo (MP-RAGE) scans; B(1)-calibration scans when applicable; and an axial proton density-T(2) dual contrast (i.e., echo) fast spin echo/turbo spin echo (FSE/TSE) for pathology detection. ADNI MRI methods seek to maximize scientific utility while minimizing the burden placed on participants. The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom-based monitoring of all scanners could be used as a model for other multisite trials.
Related papers
- Clinical diagnosis of Alzheimer's disease1984
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment2005
- Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review2013
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011
- Parkinsonism1967
Metadata from OpenAlex (CC0). Citations are generated from the published record.